dextroamphetamine has been researched along with Parkinsonian Disorders in 10 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heckman, PRA | 1 |
| Blokland, A | 1 |
| Van Goethem, NP | 1 |
| Van Hagen, BTJ | 1 |
| Prickaerts, J | 1 |
| Bagga, V | 1 |
| Dunnett, SB | 1 |
| Fricker, RA | 1 |
| Ourednik, J | 1 |
| Ourednik, V | 1 |
| Lynch, WP | 1 |
| Schachner, M | 1 |
| Snyder, EY | 1 |
| Steindler, DA | 1 |
| GILLINGHAM, FJ | 1 |
| KALYANARAMAN, S | 1 |
| DRAPER, IT | 1 |
| JOHNS, RJ | 1 |
| LAVERTY, R | 1 |
| SHARMAN, DF | 1 |
| Shukla, S | 2 |
| Agrawal, AK | 2 |
| Chaturvedi, RK | 2 |
| Seth, K | 2 |
| Srivastava, N | 1 |
| Sinha, C | 1 |
| Shukla, Y | 1 |
| Khanna, VK | 1 |
| Seth, PK | 2 |
| Chauhan, S | 1 |
| Ahmad, A | 1 |
| Srinivasan, J | 1 |
| Schmidt, WJ | 1 |
10 other studies available for dextroamphetamine and Parkinsonian Disorders
| Article | Year |
|---|---|
The mediating role of phosphodiesterase type 4 in the dopaminergic modulation of motor impulsivity.
Topics: Aminopyridines; Animals; Benzamides; Brain; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropa | 2018 |
The 6-OHDA mouse model of Parkinson's disease - Terminal striatal lesions provide a superior measure of neuronal loss and replacement than median forebrain bundle lesions.
Topics: Animals; Apomorphine; Corpus Striatum; Dextroamphetamine; Dopamine Agonists; Dopamine Uptake Inhibit | 2015 |
Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aging; Animals; Cell Count; Cell Survival; Dextroamphe | 2002 |
Neural stem cells, scaffolds, and chaperones.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biocompatible Materials; Cell Survival; Dextr | 2002 |
PARKINSON'S DISEASE.
Topics: Amitriptyline; Dextroamphetamine; Humans; Imipramine; Muscle Relaxants, Central; Neurosurgery; Orphe | 1963 |
THE DISORDERED MOVEMENT IN PARKINSONISM AND THE EFFECT OF DRUG TREATMENT.
Topics: Atropine; Dextroamphetamine; Diphenhydramine; Drug Therapy; Geriatrics; Humans; Kinetics; Motor Skil | 1964 |
MODIFICATION BY DRUGS OF THE METABOLISM OF 3,4-DIHYDROXYPHENYLETHYLAMINE, NORADRENALINE AND 5-HYDROXYTRYPTAMINE IN THE BRAIN.
Topics: Animals; Atropine; Behavior, Animal; Brain; Brain Chemistry; Cats; Caudate Nucleus; Cerebral Cortex; | 1965 |
Co-transplantation of carotid body and ventral mesencephalic cells as an alternative approach towards functional restoration in 6-hydroxydopamine-lesioned rats: implications for Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Binding, Competitive; Brain Tissue Transplantation; Carotid | 2004 |
Restorative potential of dopaminergic grafts in presence of antioxidants in rat model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Ascorbic Acid; Brain Tissue Transplantation; | 2004 |
Serotonergic influence on the potentiation of D-amphetamine and apomorphine-induced rotational behavior by the alpha2-adrenoceptor antagonist 2-methoxy idazoxan in hemiparkinsonian rats.
Topics: Adrenergic Agents; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; A | 2005 |